INTRACELLULAR ANTIBODIES (INTRABODIES) FOR GENE THERAPY OF INFECTIOUS DISEASES

1997 ◽  
Vol 51 (1) ◽  
pp. 257-283 ◽  
Author(s):  
Isaac J. Rondon ◽  
and Wayne A. Marasco
Keyword(s):  
Gene Therapy ◽  
Infectious Diseases

Gene therapy for infectious diseases: the AIDS model

1994 ◽  
Vol 10 (4) ◽  
pp. 139-144 ◽  
Author(s):  
Eli Gilboa ◽  
Clay Smith
Keyword(s):  
Gene Therapy ◽  
Infectious Diseases ◽  
Aids Model

scholarly journals Gene Therapy for Infectious Diseases

1998 ◽  
Vol 11 (1) ◽  
pp. 42-56 ◽  
Author(s):  
Bruce A. Bunnell ◽  
Richard A. Morgan
Keyword(s):  
Gene Therapy ◽  
Infectious Diseases ◽  
Infectious Agent ◽  
Catalytic Rna ◽  
Single Chain ◽  
Gene Therapies ◽  
Single Chain Antibodies ◽  
Wide Range ◽  
Management Approaches ◽  
I Gene

SUMMARY Gene therapy is being investigated as an alternative treatment for a wide range of infectious diseases that are not amenable to standard clinical management. Approaches to gene therapy for infectious diseases can be divided into three broad categories: (i) gene therapies based on nucleic acid moieties, including antisense DNA or RNA, RNA decoys, and catalytic RNA moieties (ribozymes); (ii) protein approaches such as transdominant negative proteins and single-chain antibodies; and (iii) immunotherapeutic approaches involving genetic vaccines or pathogen-specific lymphocytes. It is further possible that combinations of the aforementioned approaches will be used simultaneously to inhibit multiple stages of the life cycle of the infectious agent.

Gene Therapy for Infectious Diseases

2001 ◽  
pp. 127-146
Author(s):  
Gökhan M. Mutlu ◽  
H. Ari Jaffe
Keyword(s):  
Gene Therapy ◽  
Infectious Diseases
Sign in / Sign up

Export Citation Format

Share Document